Risk factor
Very poor trading liquidity
Profitability factor
Undervalued vs peers
About
Established in Tokyo, Japan, in 1973, Medikit Co.,Ltd. specializes in the development, manufacturing, and global distribution of advanced medical devices for vascular access. Their comprehensive product portfolio encompasses various intravenous (IV) catheters, such as Supercath 5, Supercath Z3V, and Supercath Ztu-V. They further provide solutions for hemodialysis, including Supercath PRO, Supercath NEO, and Supercath Clampcath, alongside interventional products like Supersheath and Mongoose. These critical medical instruments find application in diverse healthcare settings, notably in anesthesiology departments, operating theaters, intensive care units (ICUs), and within both dialysis and cardiology facilities. Medikit Co.,Ltd. expands its market reach by leveraging a network of distributors, serving approximately 20 countries and territories throughout the European Union and the Americas.
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD.